Selective in ipamorelin research means selective for a specified response under specified conditions. The frequently cited difference concerns particular hormone measurements in animal experiments. Receptor selectivity, hormone-response selectivity and clinical safety are different questions. Keeping them separate makes the original research much easier to read.
What does selectivity actually describe?
Ask “selective for what?” before treating the word as a conclusion. A receptor question asks where a compound acts compared with other targets. An endocrine question asks which measured hormones change under particular experimental conditions. A safety question asks about harmful outcomes. Evidence addressing one does not automatically answer the others.
When reading ipamorelin research, the important distinction is between a target-level description and a pattern of observed responses. Saying that a compound belongs to a receptor-agonist class does not tell you every response that might follow in every tissue. Equally, observing no significant change in one measurement does not establish that the compound has no other effects.
What the original ipamorelin comparison found
In Raun and colleagues’ 1998 primary study, investigators examined ipamorelin in rat pituitary cells and animal experiments. The swine experiments included GHRP-2 as a comparator. GHRP-2 showed higher potency but lower maximum GH response than ipamorelin in that experimental setting.
The investigators also measured other hormones. GHRP-2 and GHRP-6 increased ACTH and cortisol in the tested swine conditions; ipamorelin did not produce levels significantly different from the GHRH comparison. That is a specific endocrine-response finding. It should not be rewritten as “ipamorelin never affects cortisol” or “GHRP-2 is unsafe.” Neither conclusion follows from the experiment.
Potency and maximum response are not interchangeable
Potency concerns the amount or concentration associated with a specified response. Maximum response concerns how large the measured response becomes in that system. A compound can rank differently on these two measures. Describing either one simply as strength throws away information.
A useful reading habit is to finish the sentence: “More potent for this endpoint, in this model, compared with this compound.” That wording is less catchy than a ranking, but it preserves the information a researcher actually needs. It also prevents an animal assay result from quietly turning into a recommendation for a person.
Why the assay matters
A separate 2003 primary study by Holst and colleagues investigated signaling in cells expressing the ghrelin receptor. It examined constitutive signaling and ligand responses, including ipamorelin. This illustrates another level of measurement: receptor signaling in a cellular assay, rather than circulating hormone concentrations in a whole animal.
These are not interchangeable readouts. The cell experiment can help investigate a signaling mechanism; the animal experiment includes additional biological systems. Neither should be described as a test of a Dissolv vial, and neither supplies a general-purpose winner for all research questions.
Read a comparison without building a false ranking
When two descriptions appear to disagree, first check whether they discuss the same endpoint. A claim about receptor activity may be placed beside a claim about GH release even though the measurements differ. Next check whether the comparison was performed directly in the same experiment or assembled from separate papers.
Keep a short evidence note with three lines: what was measured, where it was measured, and which conclusion remains unsupported. For the 1998 comparison, the note should preserve the animal context and the particular endocrine endpoints. It should not end with a preferred compound for sleep, recovery, muscle growth or another human outcome the experiment did not establish.
Reading the Ipamorelin catalog entry
Dissolv lists Ipamorelin 5mg as a research material. Open the listing to examine its stated identity and available product details. Confirm the current specification and lot documentation rather than treating a catalog photograph or this article as an analytical certificate.
Research-use materials are not for human or veterinary use. This link identifies a catalog entry; it does not recommend administration, combination or therapeutic selection.
By Dissolv Labs. Sources checked October 18, 2026. Educational interpretation of selected primary experiments, not a systematic review or independent medical review.
